• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-032
Device Problem Insufficient Information (3190)
Patient Problems Purulent Discharge (1812); Endocarditis (1834); Staphylococcus Aureus (2058); Complaint, Ill-Defined (2331)
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.A review of the device history record was not possible since the serial number was unavailable.Based on the information received, the cause of the reported incident could not be conclusively determined.Note, this mdr was originally reported under mfr report # 2135147-2015-00105 but due to a technical issue, i was advised to void it and repackage the submission.Mfr report # 2135147-2015-00110 is intended to replace mfr report # 2135147-2015-00105.
 
Event Description
According to the article "late bacterial endocarditis of an amplatzer atrial septal defect occluder device" (doi 10.1016/j.Amjcard.2009.09.011), a (b)(6) male with a large secundum atrial septal defect (asd) was implanted with a 32mm amplatzer septal occluder (aso).Approximately 2.5 years after implant, the patient presented with a week-long history of fever.A urinalysis revealed staphylococcus aureus bacteremia.A transesophageal echocardiography revealed a 1.5 x 1.5cm mobile mass on the left atrial side of the aso consistent with vegetation.When the aso was explanted, the left atrial side of the device was poorly endothelialized and a purulent fluid was present between the aso and atrial septum that was culture negative.Post-operatively, the patient received six weeks of vancomycin and recovered without further complications.The article briefly referenced a (b)(6) child with mitral valve prolapse who developed late aso endocarditis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5104003
MDR Text Key26778524
Report Number2135147-2015-00110
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Report Date 09/09/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/25/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number9-ASD-032
Device Catalogue Number9-ASD-032
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-